Latest Biotech News

The Food and Drug Administration has greenlighted clinical trials for transplantation of gene-edited pig kidneys into humans, marking a major milestone in xenotransplantation research. These...

Israeli startup RedC Biotech is pioneering large-scale production of universal red blood cells derived from stem cells to alleviate global blood shortages. Utilizing bioreactors capable of...

NRG Therapeutics secured $67 million in a funding round featuring Merck KGaA and Novartis venture arms, supporting development of its mitochondrial-targeted therapies for neurodegenerative...

Pfizer and BioNTech presented new data demonstrating that their updated COVID-19 vaccine booster induces increased neutralizing antibodies against circulating SARS-CoV-2 strains. This evidence...

Takeda and Alkermes disclosed encouraging Phase 3 and Phase 2 data for their orexin receptor 2-selective agonists, oveporexton and alixorexton, respectively, in treating narcolepsy type 1. Both...

Ionis Pharmaceuticals shares surged 42% after reporting positive results from two pivotal Phase III trials evaluating olezarsen for severe hypertriglyceridemia. The antisense oligonucleotide...

Israeli startup RedC Biotech is pioneering the large-scale production of lab-grown red blood cells derived from stem cells, aiming to address global blood shortages that cause millions of deaths...

Recent clinical developments in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) reveal promising advances in antibody-drug conjugates (ADCs) and targeted therapies. At the...

Clinical trials presented at WCLC 2025 demonstrate advances in EGFR-mutated NSCLC management through combinatory strategies. Tagrisso (osimertinib) combined with chemotherapy reduced death risk by...

Draig Therapeutics, a clinical-stage neuropsychiatry company co-founded by Cardiff University scientists, secured $140 million in Series A funding led by Access Biotechnology. The company focuses...

Rapport Therapeutics announced positive topline results from a Phase 2a trial of its focal onset seizure medication RAP-219, achieving the primary endpoint by significantly reducing long seizure...

NRG Therapeutics has raised $67 million in financing from investors including the venture arms of Merck KGaA and Novartis to advance its mitochondrial-targeted drug aimed at neurodegenerative...

Pfizer is supporting global initiatives deploying artificial intelligence (AI) to enhance early identification of transthyretin cardiac amyloidosis (ATTR-CM), a rare and underdiagnosed cause of...

MIT Technology Review’s 2025 Innovator of the Year, Sneha Goenka, has advanced ultrafast genome sequencing technology that delivers genetic diagnoses in under eight hours, a dramatic acceleration...

Junshi Biosciences announced positive Phase 3 results for its anti-IL-17A monoclonal antibody JS005 in treating moderate-to-severe plaque psoriasis among Chinese patients, achieving primary and...

A multidisciplinary research team developed Fentanyl-Hunter, a machine learning-driven platform for comprehensive screening of fentanyl compounds and their metabolites in biological and...

Recent landmark studies presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference have revealed transformative advances in lung cancer therapy....

Advancements in small cell lung cancer (SCLC) management were spotlighted at IASLC 2025, with novel therapeutic options gaining traction. The first-in-human Phase 1 trial of DLL3-targeting ADC...

Immunotherapy advancements continue to refine lung cancer treatment paradigms. The Phase 3 EA5181 trial demonstrated no overall survival benefit from concurrent plus consolidative durvalumab...

Artificial intelligence (AI) and digital technologies are rapidly reshaping medical diagnostics and clinical trial execution. Pfizer-led initiatives employing AI algorithms are accelerating early...